## Gene expression anti-profiles

- molecular methods for cancer detection, prognosis and treatment matching will be the basis of individualized medicine
- gene expression profile methods have been subject of study for decades
- very few proposed predictors are translated to the clinic
- one of the biggest culprits is lack of replicability of results in preliminary studies

---

<div class="centered">
<img src="img/antiprofile.png" style="height: 400px;"/>
</div>

_anti-profile score_: measures sample-specific deviation from normal expression in consistently hyper-variable genes

<footer class="source">BMC Bioinformatics, 2013</footer>

---

- **Feature selection**: top 100 genes with greatest **hyper-variable** expression in tumor:

$$
\log_2 \frac{\text{std. dev}_{\text{cancer}}}{\text{std. dev}_{\text{normal}}}
$$

- **Range of normal expression**: 

$$
\mathrm{med} \, \text{normal expression}_g \pm 5 \times \mathrm{mad} \, \text{normal expression}_g
$$

- **anti-profile score**: number of genes in sample where expression is outside normal range

---

<div class="centered">
<img src="img/stable.png" style="max-height: 85%; max-width: 85%;"/>
</div>

Good cross-experiment properties  
Stability in _normal_ expression across experiments

<footer class="source">BMC Bioinformatics, 2013</footer>

---

<div class="centered">
<img src="img/aucs.png" style="max-height: 45%; max-width: 45%;"/>
</div>

Prediction in leave-one-tissue out experiment  

<footer class="source">BMC Bioinformatics, 2013</footer>

---

<div class="centered">
<img src="img/progression.png" style="max-height: 50%; max-width: 50%"/>
</div>

Anti-profile score distinguishes between stages in tumor progression

<footer class="source">Cancer Informatics, 2015</footer>

---

<div class="centered">
<img src="img/progression_meth.png" style="max-height: 80%; max-width: 80%"/>
</div>

DNA methylation anti-profiles score distinguishes between stages in tumor progression

<footer class="source">Cancer Informatics, 2015</footer>

---

<div class="centered">
<img src="img/prognosis.png" style="max-height: 70%; max-width: 70%"/>
</div>

Stratification based on anti-profile score

<footer class="source">Cancer Informatics, 2015</footer>

---

<div class="centered">
<img src="img/prognosis.jpg" style="max-height: 45%; max-width: 45%"/>
</div>

Stratification of breast samples based on anti-profile score

<footer class="source">Cancer Informatics, 2015</footer>

## Summary

>- Simple counting scheme produces robust stable and accurate (anti)-profiles  
>- Nice prediction properties _across experiments_ and _across tissue types_  
>- Captures increasing hyper-variability associated with progression and prognosis

## Anomaly Classification

- Distinguish observations from two _anomalous_ groups (e.g., adenoma vs. tumor)
- How can we incorporate the fact that we are classifying anomalies?
- Why (and when) is it worth doing that?
- Using function approximation methods to study predictor stability

## Summary

>- Profiles learned based on hyper-variability show consistent behavior across tissues and across experiments in tumor prognosis and progression
>- We can extend the general anti-profile idea to a function approximation setting
>- Use sensitivity-based cross-validation error bounds to characterize the effect of incorporating normal observations when classifying between anomalies
>- Incorporating normal samples when building anomaly predictors improves stability and prediction performance

